And, as Bialik notes in her essay, more than 4,000 Americans have filed lawsuits against GLP-1 drug manufacturers over what they claim are life-altering side effects
Dry eye disease: an update in 2022
Users of triple agonists should be particularly vigilant about nutritional monitoring, as the more potent appetite suppression and metabolic effects may accelerate nutrient depletion
46, 10131075 (Academic Press, 2015)
Pharmaceuticals GLP-1 Receptor Agonist Market GLP-1 Receptor Agonist Market Size, Trends, Share, Growth, and Regional Forecast, 2026 to 2033 GLP-1 Receptor Agonist Market by Product (Ozempic, Wegovy, Rybelsus, Victoza, Zepbound, Saxenda, Trulicity, Mounjaro, Others), Indication (Type 2 Diabetes mellitus, Obesity, Others), Route of Administration (Parenteral, Oral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Analysis from 2026 to 2033 December 2025 210 Pages Author : Abhijeet Surwase GLP-1 Receptor Agonist Market Share and Trends Analysis The global GLP-1 receptor agonist market size is estimated to grow from US$ 74.4 billion in 2026 to US$ 232.8 billion by 2033
